Published in Gene Therapy Weekly, June 1st, 2006
Drugs that could comprise a predicted spike in pharmaceutical and biotechnology productivity are among those selected this year by the editors of R & D Directions as the best and brightest of the future's new medicines. This fifth annual report on 100 great investigational drugs in development presents compounds distinguishing themselves as innovative, first in class, or clearly advanced compared with those...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.